Skip to main content
The BMJ logoLink to The BMJ
editorial
. 1989 Jan 21;298(6667):136–137. doi: 10.1136/bmj.298.6667.136-a

Botulinum toxin: a new ally of an old adversary.

R C Humphry
PMCID: PMC1835496  PMID: 2493831

Full text

PDF
136

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blitzer A., Brin M. F., Fahn S., Lange D., Lovelace R. E. Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias. Laryngoscope. 1986 Nov;96(11):1300–1301. [PubMed] [Google Scholar]
  2. Clarke J. R., Spalton D. J. Treatment of senile entropion with botulinum toxin. Br J Ophthalmol. 1988 May;72(5):361–362. doi: 10.1136/bjo.72.5.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dunn W. J., Arnold A. C., O'Connor P. S. Botulinum toxin for the treatment of dysthyroid ocular myopathy. Ophthalmology. 1986 Apr;93(4):470–475. doi: 10.1016/s0161-6420(86)33713-8. [DOI] [PubMed] [Google Scholar]
  4. Elston J. S. Botulinum toxin treatment of hemifacial spasm. J Neurol Neurosurg Psychiatry. 1986 Jul;49(7):827–829. doi: 10.1136/jnnp.49.7.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Elston J. S., Russell R. W. Effect of treatment with botulinum toxin on neurogenic blepharospasm. Br Med J (Clin Res Ed) 1985 Jun 22;290(6485):1857–1859. doi: 10.1136/bmj.290.6485.1857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kirkness C. M., Adams G. G., Dilly P. N., Lee J. P. Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology. 1988 Apr;95(4):473–480. doi: 10.1016/s0161-6420(88)33163-5. [DOI] [PubMed] [Google Scholar]
  7. Magoon E., Scott A. B. Botulinum toxin chemodenervation in infants and children: an alternative to incisional strabismus surgery. J Pediatr. 1987 May;110(5):719–722. doi: 10.1016/s0022-3476(87)80009-4. [DOI] [PubMed] [Google Scholar]
  8. Mauriello J. A., Jr Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin. Neurology. 1985 Oct;35(10):1499–1500. doi: 10.1212/wnl.35.10.1499. [DOI] [PubMed] [Google Scholar]
  9. Melling J., Hambleton P., Shone C. C. Clostridium botulinum toxins: nature and preparation for clinical use. Eye (Lond) 1988;2(Pt 1):16–23. doi: 10.1038/eye.1988.5. [DOI] [PubMed] [Google Scholar]
  10. Scott A. B. Antitoxin reduces botulinum side effects. Eye (Lond) 1988;2(Pt 1):29–32. doi: 10.1038/eye.1988.7. [DOI] [PubMed] [Google Scholar]
  11. Scott A. B. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981;79:734–770. [PMC free article] [PubMed] [Google Scholar]
  12. Scott A. B. Injection treatment of endocrine orbital myopathy. Doc Ophthalmol. 1984 Aug 15;58(1):141–145. doi: 10.1007/BF00140912. [DOI] [PubMed] [Google Scholar]
  13. Scott A. B., Kraft S. P. Botulinum toxin injection in the management of lateral rectus paresis. Ophthalmology. 1985 May;92(5):676–683. doi: 10.1016/s0161-6420(85)33982-9. [DOI] [PubMed] [Google Scholar]
  14. Stell R., Thompson P. D., Marsden C. D. Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry. 1988 Jul;51(7):920–923. doi: 10.1136/jnnp.51.7.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tsui J. K., Eisen A., Stoessl A. J., Calne S., Calne D. B. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet. 1986 Aug 2;2(8501):245–247. doi: 10.1016/s0140-6736(86)92070-2. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES